Xuemei Jia

19PUBLICATIONS
33CO-AUTHORS
Obstetrics and gynaecologyPredictive and prognostic markersChemotherapyMolecular targetsNanoelectronics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 25, 2026
Diffuse Uterine Leiomyomatosis: A Retrospective Study of Clinical Features and Outcomes in Nine Cases with Literature Review.

|Feb 24, 2025
Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes.

Shengjie Xu, Ridwan Abdifatah Mohamed, Juan Xu

|Oct 26, 2024
Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer.

Xin Cui, Juan Xu, Xuemei Jia

|Feb 17, 2024
Tripartite-motif 3 represses ovarian cancer progression by downregulating lactate dehydrogenase A and inhibiting AKT signaling.

Yu Cong, Xin Cui, Yaqian Shi

|Oct 10, 2023
NAT10-dependent N4-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation.

Qin Yan, Jing Zhou, Ziyu Wang

|Sep 04, 2023
IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6 A-dependent manner.

Yaqian Shi, Xueyou Xiong, Yu Sun

Pageof 4

Frequent Collaborators

7 joint publications

Juan Xu

3 joint publications

Zhe Geng

2 joint publications

Pengfei Xu

2 joint publications

Shou-Jiang Gao